This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,194.80 firm fixed-price delivery order is for the supply of 4566749104 - Capecitabine 500 mg Tablets 120's, a specialty oncology medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,852.68, is a delivery order for the supply of 4,566,120,716 units of Capecitabine 500 mg tablets. The contract has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,697,687 units of the medication Capecitabine 500 mg tablets. The $1,316.22 firm fixed-price contract has a ceiling value and an ultimate completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,115.50 fixed-price contract is for the supply of 120 tablets of the medication Capecitabine 500 mg. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN4L8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,315.20 firm-fixed-price delivery order is for the supply of 4,560,983,802 units of the prescription drug Capecitabine 500 mg tablets. The award has an ultimate completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (SPE2DB24FWQ83) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025. The contract is for the delivery of 4565466912 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, at a firm fixed price of $1,057.14. The award has a completion date of August 16, 2024 and was not set aside for any special...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $483.30 to Amerisourcebergen Drug Corporation for the provision of 120 tablets of 500mg capecitabine. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform under the contract from its location in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its pharmaceutical procurement programs. No subcontractors or...
The Defense Logistics Agency awarded a delivery order valued at approximately $1,348 to Amerisourcebergen Drug Corporation for the provision of 120 tablets of capecitabine at 500mg each. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 11, 2023 under the firm fixed price contract awarded on August 10, 2023. The Defense Logistics Agency facilitates worldwide logistics support for the United States...
This federal contract award, valued at $10,423.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Abiraterone Acetate 500 mg tablets, a medication used to treat prostate cancer. This contract is not designated as a set-aside, indicating open competition. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, valued at $1,165.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,998,854 tablets of Abiraterone Acetate 250 mg, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 23, 2025. This contract is not set aside and is open to full and open competition....